US pharmaceutical distributor Cardinal Health

05 September 1994 00:00  [Source: ICB]

US pharmaceutical distributor Cardinal Health is to acquire Humiston Keeling for an estimated $40m. Cardinal currently stands as the US's third largest pharmaceutical distributor with annual revenues of about $6bn, whilst Humiston's sales stand at about $830m. The purchase; which is scheduled for completion in July, is subject to regulatory approval.





AddThis Social Bookmark Button

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly